POS Company- $0.26 per share

Discussion in 'Akers Biosciences' started by anonymous, Jan 26, 2018 at 1:35 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Rule #5 unqualified people who pass themselves off as competent businessmen make way too much money.
     

  2. anonymous

    anonymous Guest

    LOL.....ol' chap found themselves another creative financial way to manipulate the numbers and Nasdaq. You re-gained compliance with Nasdaq. Won't last long though. Circling the drain a-holes.
     
  3. anonymous

    anonymous Guest

    The company, which has about a dozen employees, generated sales of just under $1.7 million and recorded a net loss of $10.8 million in 2018.

    The Thorofare company is selling 1.99 million units — each consisting of one share of common stock and one preferred stock warrant to purchase one share of series C convertible preferred stock — at $4 per unit.

    Akers, in documents filed with the Securities and Exchange Commission, said it plans to use the estimated $7.96 million in proceeds from the public stock sale for working capital and other general corporate purposes, which may include funding the "exploration of strategic alternatives." Exploration of strategic alternatives = is it viable and profitable to sell pot on the open market that will eventually get back to kids in elementary schools and playgrounds. Now don't forget to creatively line your pockets with that $7.96 million dollars raised by splicing and dicing the stock before declaring bankruptcy. LOL
     
  4. anonymous

    anonymous Guest

    ++++++++++++++++

    UNITED STATES DISTRICT COURT
    DISTRICT OF NEW JERSEY
    CALE WATTS, derivatively on behalf of
    AKERS BIOSCIENCES, INC., Case No.: 2:18-cv-15992

    Plaintiff, EXHIBIT B

    vs.
    NOTICE OF SETTLEMENT
    JOHN J. GORMALLY, GARY M. RAUCH,
    RAYMOND F. AKERS, JR., BILL J.
    WHITE, RICHARD C. TARBOX III, and
    CHRISTOPHER C. SHREIBER, TO CURRENT AKERS
    STOCKHOLDERS

    Defendants,

    and

    AKERS BIOSCIENCES, INC.,

    Nominal Defendant.

    LOL.......too rich. So funny. Akers stockholders sue Akers leadership. Inside this.......Akers stockholders sue Ray Akers himself. Correct me if I'm wrong, but I think this is separate from the class-action suit that is still going on and separate from another settlement they already agreed to pay out. Truly, Kharma can be a blessed thing with much more to come. The name Akers has forever been tainted. I predict they'll re-brand to sell pot or close down Akers completely and open up another company that will be destined to fail.
     
  5. anonymous

    anonymous Guest

    Smoking dope now?



    UNITED STATES DISTRICT COURT
    DISTRICT OF NEW JERSEY
    CALE WATTS, derivatively on behalf of
    AKERS BIOSCIENCES, INC., Case No.: 2:18-cv-15992

    Plaintiff, EXHIBIT B

    vs.
    NOTICE OF SETTLEMENT
    JOHN J. GORMALLY, GARY M. RAUCH,
    RAYMOND F. AKERS, JR., BILL J.
    WHITE, RICHARD C. TARBOX III, and
    CHRISTOPHER C. SHREIBER, TO CURRENT AKERS
    STOCKHOLDERS

    Defendants,

    and

    AKERS BIOSCIENCES, INC.,

    Nominal Defendant.

    LOL.......too rich. So funny. Akers stockholders sue Akers leadership. Inside this.......Akers stockholders sue Ray Akers himself. Correct me if I'm wrong, but I think this is separate from the class-action suit that is still going on and separate from another settlement they already agreed to pay out. Truly, Kharma can be a blessed thing with much more to come. The name Akers has forever been tainted. I predict they'll re-brand to sell pot or close down Akers completely and open up another company that will be destined to fail.[/QUOTE]